It's so cool watching WNXL, they're rippers. :3
#WNXL #NXL #Paintball

👉 Si trabajas en BESS, hibridación o integración en red, nos vemos en Sevilla.

#RENMAD2026 #nXL

BREAKING NEWS: ( NASDAQ: #NXL ) Nexalin Technology Shares Surge with Launch of AI-Powered Virtual Clinic

Published Peer-Reviewed Study Demonstrates Nexalin’s DIFS™ Neurostimulation Improves Attention and Normalizes Brain Activity in Patients with ADHD Nexalin Technology (Nasdaq: NXL) announced a peer‑reviewed, randomized double‑blind sham‑controlled trial published in Molecular Psychiatry showing four weeks of its non‑invasive DIFS™ neurostimulation improved attention and normalized brain activity in adults with ADHD.In 56 adults, active treatment produced a 10.1‑point average improvement on the Adult ADHD Self‑Report Scale versus 5.5‑points for sham (4.6‑point separation, p < 0.001), plus MEG/EEG evidence of reduced excessive gamma activity and restored network communication. Treatment was well tolerated with no serious adverse events reported.

#NXL #NXLIW Published Peer-Reviewed Study Demonstrates Nexalin’s DIFS™ Neurostimulation Improves Attention and Normalizes Brain Activity in Patients with ADHD

www.stocktitan.net/news/NXL/published-peer-...

#NXL #NXLIW Nexalin Technology Completes FDA Q-Submission Meeting for Gen-2 SYNC™ Neurostimulation Console in Alzheimer’s Disease Program

www.stocktitan.net/news/NXL/nexalin-technol...

#NXL #NXLIW Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on December 4

www.stocktitan.net/news/NXL/join-nexalin-te...

youtu.be/r8dnlM_tTOQ

The Docs are back, please consider helping rebound my Youtube with a comment, a like, a watch.

#paintball #media #midwest #photographer #videographer #jt #planeteclipse #action #nxl #tampabay

Jedi Skill, Force Loading
#paintball #jt #viture #planeteclipse #nxl #worldcup #nikon #z8 #sports #action #florida #media

Team: BR Factory Division 4 X-Ball
Event: NXL World Cup 2025

Nexalin’s 15 Milliamp Neurostimulation Device Demonstrates Promising Results in Treating Gambling Disorder with Alcohol Use Comorbidity Nexalin Technology (Nasdaq: NXL) reported a peer-reviewed case report in The American Journal on Addictions showing promising results using its 15 mA neurostimulation device to treat gambling disorder comorbid with alcohol use disorder.In a single patient treated at Shanghai Mental Health Center, 20 outpatient sessions over 10 days (15 mA at 77.5 Hz for 40 minutes each) produced complete abstinence from gambling and alcohol, improved cognitive control, and no adverse effects during a three-month follow-up. The study (ClinicalTrials.gov NCT06195995) received ethics approval. The device is approved in China for depression and insomnia. Authors recommend larger controlled trials to confirm findings.

#NXL #NXLIW Nexalin’s 15 Milliamp Neurostimulation Device Demonstrates Promising Results in Treating Gambling Disorder with Alcohol Use Comorbidity

www.stocktitan.net/news/NXL/nexalin-s-15-mi...

Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for the Treatment of Alzheimer’s Disease and Dementia Nexalin Technology (Nasdaq: NXL) announced that the U.S. Food and Drug Administration accepted its Q-Submission for the Gen-2 SYNC console for treatment of Alzheimer’s disease and dementia on November 5, 2025.The acceptance schedules a regulatory meeting later in 2025 to discuss clinical trial design, endpoints, statistical plans and the regulatory pathway toward a potential U.S. Investigational Device Exemption (IDE).Company-reported supportive signals include encouraging internal data, published studies showing improved cognitive performance, no serious adverse events across international use, and EEG/qEEG evidence of waveform-induced neural connectivity changes for dementia-related conditions.

#NXL #NXLIW Nexalin Technology’s Q-Submission for Gen-2 SYNC Accepted by U.S. FDA for the Treatment of Alzheimer’s Disease and Dementia

www.stocktitan.net/news/NXL/nexalin-technol...

Nexalin’s DIFS™ Neurostimulation Shows Cognitive and Brain Network Improvements in Alzheimer’s and Dementia Across Three Peer-Reviewed Studies Nexalin Technology, Inc. (Nasdaq:

#NXL #NXLIW Nexalin’s DIFS™ Neurostimulation Shows Cognitive and Brain Network Improvements in Alzheimer’s and Dementia Across Three Peer-Reviewed Studies

www.stocktitan.net/news/NXL/nexalin-s-difst...

Nexalin Technology Announces Additional Positive Clinical Results in Alzheimer’s Disease with Gen-2 SYNC Neurostimulation Device Nexalin Technology (Nasdaq: NXL) reported peer-reviewed clinical results (Radiology, Oct 8, 2025) showing its Gen-2 SYNC 40-Hz, 15 mA DIFS neurostimulation device produced statistically significant cognitive gains and measurable brain-connectivity changes in mild Alzheimer’s disease.Key findings: significant MMSE and MoCA score improvements versus sham (P = .001 and .03), increased hippocampal-cortical and network functional connectivity on resting-state fMRI, a connectivity–naming-test correlation (r = 0.65, FDR-adjusted P = .008), and no reported adverse events. Device has regulatory approvals for other indications in China, Brazil, and Oman.

#NXL #NXLIW Nexalin Technology Announces Additional Positive Clinical Results in Alzheimer’s Disease with Gen-2 SYNC Neurostimulation Device

www.stocktitan.net/news/NXL/nexalin-technol...

Ein starkes Signal für den deutschen Turnierpaintball:
Die NXL – die größte Paintball-Profiliga der Welt -
erkennt DIE LIGA offiziell als Feeder League an.

Mehr Infos findet Ihr hier: dieliga-paintball.de

#DIELIGA #PaintballGermany #NXL #Turnierpaintball #GermanPaintball #news

Nexalin Technology Announces Issuance of U.S. Patent Covering HALO™ Clarity Device Featuring DIFS™ Technology Nexalin Technology (NASDAQ: NXL) has secured U.S. Design Patent No. D1,092,758 for its HALO™ Clarity neuromodulation device, providing 15 years of design protection. The device utilizes the company's proprietary Deep Intracranial Frequency Stimulation (DIFS™) technology to deliver non-invasive, drug-free treatment for mental health and neurological conditions.The HALO™ Clarity system enables at-home, professionally supervised treatment with remote monitoring capabilities. The company is conducting multiple clinical studies across various indications including anxiety, insomnia, PTSD, and mild traumatic brain injury. The FDA has already provided consensus on pivotal trial designs for anxiety and insomnia indications.The DIFS™ platform has demonstrated safety and efficacy signals in over two dozen trials worldwide. Nexalin has completed usability, safety, and design verification testing and is scaling manufacturing for broader clinical deployment.

#NXL #NXLIW Nexalin Technology Announces Issuance of U.S. Patent Covering HALO™ Clarity Device Featuring DIFS™ Technology

www.stocktitan.net/news/NXL/nexalin-technol...

Nuix share price Nuix (ASX:NXL) is an asset listed on the ASX, and part of the Information Technology sector. Grafa’s asset page shows Nuix’s share price, chart, trading volume,

Nuix ( #NXL ) has released " Investor Day Presentation " on Tue 23 Sep at 08:26 AEST #today #Australia #media #Strategy #live

Gdzie ta kawa, gdzie ta kawa? #nxl #bruxelles

WNXL European Championships 2025
📅 28–31.08.25
👉 youtube.com/@MajorLeaguePaintball

Belladonna Live:
Fri, 29 Aug – 12:00 CEST Field 3
15:30 CEST Semi Pro
17:55 CEST Pro Field
Sat, 30 Aug – 17:55 CEST Pro Field
Tune in, cheer the team on and share!💜

#WNXL #Belladonna #paintball
#NXL #NXLEurope

$537B Mental Health Market: Nexalin Tech Showcases AI-Powered Brain Stimulation Platform for Home Use Nexalin CEO to discuss DIFS technology, Gen-3 HALO Clarity headset, and Virtual Clinic model on Sept 9. Features UC San Diego collaboration, international approvals, and AI monitoring advances.

#NXL #NXLIW Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on September 9

www.stocktitan.net/news/NXL/join-nexalin-te...

🎯 PLANET ECLIPSE CS3 ON SALE! 🎯
All CS3 markers now each €1499! 🔫
Whether you prefer "Midnight" or eye-catching colors - it's your style, your game! 🔥

But hurry - limited stock! 👀
💸 SAVE NOW: shorturl.at/yMDwx

#paintballshop #paintball #planeteclipse #cs3 #sale #shooteclipse #planet #eclipse #nxl

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks with strong volume declines, Wed Jul 16th - #ONCO #NXL #UFG #REBN #MLEC #ISPC #NWTN #PEW #ECX #IKNA #KZR - More: crystalequityresearch.com/SmCpStr/ - #smallcap

オルファの大型カッターが革新を遂げてリニューアル登場！ オルファが20年以上の人気商品である大型カッターをリニューアル。エルゴノミックデザインを採用し、使いやすさが向上。新商品は2025年7月4日発売！

オルファの大型カッターが革新を遂げてリニューアル登場！ #大阪府 #大阪市 #オルファ #NXL #EXL

オルファが20年以上の人気商品である大型カッターをリニューアル。エルゴノミックデザインを採用し、使いやすさが向上。新商品は2025年7月4日発売！

Revolutionary Mental Health Tech: Nexalin Unveils Game-Changing Treatment in $537B Market Webinar Get exclusive insights into Nexalin's breakthrough DIFS technology and Gen-3 HALO headset revolutionizing mental health treatment. Join CEO presentation June 3.

#NXL #NXLIW Join Nexalin Technology’s Exclusive Live Investor Webinar and Q&A Session on June 3

www.stocktitan.net/news/NXL/join-nexalin-te...

Getting ready for Max event 2 at blast camp
#paintball #blastcamp #nxl #jtpaintball #gisportz

Nuix share price Nuix (ASX:NXL) is an asset listed on the ASX, and part of the Information Technology sector. Grafa’s asset page shows Nuix’s share price, chart, trading volume,

Nuix ( #NXL ) has released " Trading Update " on Tue 06 May at 17:49 AEST #today #trading #Australia #media #ASX

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

Small-cap stocks with strong volume declines, Mon May 5th- #CATO #SQNS #UFI #FLGC #HRTX #SDST #WHWK #NTCL #PITX #NXL - More: crystalequityresearch.com/SmCpStr/ - #smallcap

Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”), the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, today announced the pricing of an underwritten public offering of 3,850,000 shares of its common stock

#NXL #NXLIW Nexalin Technology Announces Pricing of $5.0 Million Public Offering of Common Stock

www.stocktitan.net/news/NXL/nexalin-technol...

Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback Nexalin Technology (NASDAQ: NXL) has announced plans to submit a Q-Submission to the FDA for its Gen-2 SYNC system, marking a crucial step in its regulatory pathway. The Q-Sub aims to facilitate discussions with the FDA regarding clinical trial design for treating Alzheimer's disease, dementia, and mild cognitive impairment (MCI).This decision follows encouraging internal data and preliminary FDA feedback. The Gen-2 SYNC system features technical improvements, including a redesigned enclosure and integration of Nexalin's proprietary 15 milliamp advanced waveform. The company is also undertaking a rebranding initiative to differentiate this system from previous versions.

#NXL #NXLIW Nexalin Technology Initiates FDA Q-Submission Process for Gen-2 SYNC Following Encouraging Data and Preliminary FDA Feedback

www.stocktitan.net/news/NXL/nexalin-technol...

Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia Nexalin Technology (Nasdaq: NXL) has received institutional review board (IRB) approval in Brazil to begin a Phase II clinical trial for its Gen-2 neurostimulation device. The study will evaluate the treatment of anxiety disorders and chronic insomnia at the Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo.The trial will enroll 30 adult patients to assess the efficacy of Nexalin's Deep Intracranial Frequency Stimulation (DIFS™) technology. The primary endpoint will measure anxiety reduction using the Hamilton Anxiety Rating Scale (HAM-A), with secondary endpoints including assessments of depression symptoms, sleep quality, and clinical improvement.Led by Dr. Andre Russowsky Brunoni, the study marks Nexalin's first IRB-approved trial in Brazil. The first device has been shipped to São Paulo, with additional units and disposable electrodes scheduled for delivery soon. Results will be published in a peer-reviewed scientific journal.

#NXL #NXLIW Nexalin Technology Receives IRB Approval in Brazil and Begins Clinical Trial for Anxiety and Insomnia

www.stocktitan.net/news/NXL/nexalin-technol...